Table 6. Hazard of dying after diagnosis with colorectal cancer associated with any miRNA expression in carcinoma tissue for miRNAs not commonly expressed previously reported in the literature.

Study	miRNA	% expressing	HR	95% (CI)	p value	FDR q value
Colon
	hsa-miR-145-3p	1.9	3.36	(2.02, 5.59)	< 0.00001	0.0008
	hsa-miR-31-5p	17.2	1.70	(1.32, 2.19)	0.00004	0.0053
	hsa-miR-570-3p	2.5	0.33	(0.12, 0.89)	0.02859	0.3958
Rectal
	hsa-miR-151a-3p	33.8	0.74	(0.57, 0.97)	0.02608	0.1013
	hsa-miR-224-5p	10.0	0.66	(0.49, 0.90)	0.00785	0.0875
	hsa-miR-335-5p	6.1	0.28	(0.13, 0.64)	0.00242	0.0875
	hsa-miR-374a-5p	23.0	0.47	(0.33, 0.68)	0.00006	0.0070

¹Hazard Ratios (HR) and 95% Confidence Intervals (CI) adjusted for age, sex, AJCC stage, and MSI tumor status.